Nicholas Piramal India Ltd has announced the following Audited results for the quarter ended September 30, 2006:
The Company has posted a net profit after tax & exceptional item of Rs 670.60 million for the quarter ended September 30, 2006 as compared to Rs 549.00 million for the quarter ended September 30, 2005. Total Income (net of excise) has increased from Rs 3660.10 million for the quarter ended September 30, 2005 to Rs 4427.40 million for the quarter ended September 30, 2006.
The Unaudited Consolidated results are as follows:
The Group has posted a profit after Prior Period Items of Rs 536.90 million for the quarter ended September 30, 2006 where as the same was at Rs 456.00 million for the quarter ended September 30, 2005. Total Income is Rs 6548.30 million for the quarter ended September 30, 2006 where as the same was at Rs 3833.50 million for the quarter ended September 30, 2005.
The consolidated results for the current quarter and half year ended September 30, 2006 include the results of NPIL Pharmaceuticals (UK) Ltd, UK and Torcan Chemical Ltd, Canada which were acquired in December 2005 and the Morpeth facility acquired from Pfizer in June 2006. The figures therefore are not strictly comparable.
Figures for the Consolidated quarter ended September 30, 2005 are Audited.